Innovate In A Price Sensitive World !
The business model of the pharmaceutical industry with a third party and often public payer has always puzzled people. The patients who benefit from treatment with a medicine pay part or even nothing of the cost. Within this constrained environment, pricing is more important than ever. To set a price too high may block market access, to set a price too low will leave money on the table.
Getting the price wrong on a new drug can greatly impact its potential success. For example, if it is priced too high, physicians and payers may shy away from prescribing or reimbursing it because they might perceive that the drug provides too little benefit for the added cost. Ironically, if a new drug is priced at a discount to an existing therapy, it might also be avoided because the lower price might imply inferiority. But the goal for any pricing discussion is simple: how do we optimize revenues for this new medicine?
If you want to learn more about the aspects of pharmaceutical pricing and how to optimize revenues, you can attend on a unique 2-day practical and interactive training so you stay ahead on your competition in the pharmaceutical sector.
Learn from an international well-known expert, Raf De Wilde, with more than 20 years in-company global pricing experience. He understands the role of pricing in the current market access environment and recognizes what pricing activities over the product life cycle are needed for achieving optimal business results.
Attendees will be able to systematically identify opportunities for their companies after having followed this course.
You will gain a thorough understanding of all aspects of global price setting so that you can better explain the price of your pharmaceutical product. You will also master the modeling aspects of pharmaceutical pricing, and learn how to take cross border trade and reference pricing aspects into account. Furthermore, you will acquire the practical knowledge you need to be able to work out price competition strategies that defend the bottom line.
Venue: Guoman Charing Cross, London, UK
Rate: € 1.495,00 for two days attendance.
Get to know EPP action: Persons who are not yet familiar with EPP can obtain a discount of 15%. Contact firstname.lastname@example.org and mention 'get to know EPP – Pharma pricing training, London'. Bulk rates also available on demand.
Date: 10th and 11th of October 2012
Trainer: Raf De Wilde - Associate Vice President - United BioSource Corporation
Website for information or registration:http://goo.gl/bae87
To request further detailed information or to enquire about group discounts by email
email@example.com or by phone at +32 (0)51 320 372
Britt Dejager is a project manager at European Pricing Platform (EPP) responsible for helping to develop pricing & profit optimization know-how, focusing mainly on the Life Sciences industry.
The EPP is a not-for-profit on- and offline meeting place for pricing and profit optimization decision makers in a wide range of industries. the pricing know-how of the business manager. The interactive sharing, collecting and development of pricing knowledge are the key components.
European Pricing Platform is a ‘Not-for-Profit’ knowledge sharing place focused to support business management, pricing and profit optimization professionals and CxO-level executives in Europe over a variety of industries and sectors. Our target is to update the pricing and Profit Optimization know-how of the business manager. Our mission is to be the on- and offline pricing media for international decision makers in a wide range of industries. The interactive sharing, collecting and development of pricing and profit optimization knowledge are the key elements of our platform. To learn more visit: www.pricingplatform.eu
- European Pricing Platform:
Last updated on: 26/09/2012